Huntsman M, Marquez J, Stoddard G, Wei G, Miller A, Agarwal J
J Clin Hypertens (Greenwich). 2025; 27(2):e70021.
PMID: 39994912
PMC: 11850436.
DOI: 10.1111/jch.70021.
Bogoyavlenskiy A, Alexyuk M, Alexyuk P, Berezin V, Almalki F, Hadda T
Molecules. 2023; 28(9).
PMID: 37175179
PMC: 10179817.
DOI: 10.3390/molecules28093766.
Xiao J, Liang C, Zhang L, Li J, Liu S
Aging Dis. 2023; 14(4):1196-1213.
PMID: 37163438
PMC: 10389822.
DOI: 10.14336/AD.2023.0406.
Follonier C, Tessitore E, Handgraaf S, Carballo D, Achard M, Pechere-Bertschi A
PLoS One. 2022; 17(11):e0277653.
PMID: 36417470
PMC: 9683559.
DOI: 10.1371/journal.pone.0277653.
Sharma R, Kumar A, Majeed J, Thakur A, Aggarwal G
Egypt Heart J. 2022; 74(1):64.
PMID: 36068392
PMC: 9448845.
DOI: 10.1186/s43044-022-00303-8.
Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.
Loader J, Taylor F, Lampa E, Sundstrom J
J Am Heart Assoc. 2022; 11(11):e025289.
PMID: 35624081
PMC: 9238740.
DOI: 10.1161/JAHA.122.025289.
Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
El-Arif G, Khazaal S, Farhat A, Harb J, Annweiler C, Wu Y
Molecules. 2022; 27(7).
PMID: 35408447
PMC: 9000463.
DOI: 10.3390/molecules27072048.
Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis.
Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z
Biology (Basel). 2022; 11(2).
PMID: 35205088
PMC: 8868600.
DOI: 10.3390/biology11020221.
Mortality and Severity in COVID-19 Patients on ACEIs and ARBs-A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
Singh R, Rathore S, Khan H, Bhurwal A, Sheraton M, Ghosh P
Front Med (Lausanne). 2022; 8:703661.
PMID: 35083229
PMC: 8784609.
DOI: 10.3389/fmed.2021.703661.
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry.
Angeli F, Verdecchia P, Balestrino A, Bruschi C, Ceriana P, Chiovato L
J Cardiovasc Dev Dis. 2022; 9(1).
PMID: 35050225
PMC: 8781822.
DOI: 10.3390/jcdd9010015.
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis.
Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A
BMJ Glob Health. 2021; 6(12).
PMID: 34916273
PMC: 8678541.
DOI: 10.1136/bmjgh-2021-006434.
Hypertension and its management in COVID-19 patients: The assorted view.
El-Saber Batiha G, Gari A, Elshony N, Shaheen H, Abubakar M, Adeyemi S
Int J Cardiol Cardiovasc Risk Prev. 2021; 11:200121.
PMID: 34806090
PMC: 8590508.
DOI: 10.1016/j.ijcrp.2021.200121.
Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19.
Melillo F, Napolano A, Loffi M, Regazzoni V, Boccellino A, Danzi G
Eur J Clin Invest. 2021; 52(1):e13703.
PMID: 34706062
PMC: 8646244.
DOI: 10.1111/eci.13703.
Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality.
Fernando M, Drovandi A, Golledge J
Syst Rev. 2021; 10(1):243.
PMID: 34488897
PMC: 8421238.
DOI: 10.1186/s13643-021-01802-6.
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.
Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K
BMC Med. 2021; 19(1):212.
PMID: 34446016
PMC: 8390115.
DOI: 10.1186/s12916-021-02058-6.
Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?.
Katzenschlager S, Zimmer A, Gottschalk C, Grafeneder J, Schmitz S, Kraker S
PLoS One. 2021; 16(7):e0255154.
PMID: 34324560
PMC: 8321230.
DOI: 10.1371/journal.pone.0255154.
Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.
Loader J, Lampa E, Gustafsson S, Cars T, Sundstrom J
J Am Heart Assoc. 2021; 10(15):e021154.
PMID: 34320843
PMC: 8475700.
DOI: 10.1161/JAHA.120.021154.
Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis.
Jia N, Zhang G, Sun X, Wang Y, Zhao S, Chi W
J Clin Hypertens (Greenwich). 2021; 23(9):1651-1663.
PMID: 34320275
PMC: 8420264.
DOI: 10.1111/jch.14329.
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis.
Alsagaff M, Mulia E, Maghfirah I, Luke K, Nugraha D, Rachmi D
Diabetes Metab Syndr. 2021; 15(5):102210.
PMID: 34298269
PMC: 8282943.
DOI: 10.1016/j.dsx.2021.102210.
Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.
Sattar Y, Mukuntharaj P, Zghouzi M, Suleiman A, Attique H, Ullah W
High Blood Press Cardiovasc Prev. 2021; 28(4):405-416.
PMID: 34181203
PMC: 8237039.
DOI: 10.1007/s40292-021-00462-w.
